维普期刊资源整合服务平台（V6.5）

111篇 您的检索式：期刊名="Eur J Heart Failure"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	The carvedilol hibemarion reversible ischemia trial marker of success (CHRISMAS)显示文摘	PENNEL D RAY S	1999	Eur J Heart Failure1999，1，2：	1
2	Evaluationofimpaired left ventricular ejectionfjaction and increased dimensionsbymultiple neurohumoralI plasmaeoncentrations 显示文摘	Gmenning BA Nilsson JC Sondergaard L	2001	Eur J Heart Failure2001，12，6：	1
3	Application of NT-proBNP and BNP measurements in cardiac care a more disceming marker for the detection and evalutation of heart failure显示文摘	Seino Y Ogawa A Yamashita T	2004	Eur J Heart Failure2004，6，3：	1
4	Usefulness of bifocal pacing in patients with heart failure and intraventricular conduction delay 显示文摘	BULAVA A LUKL J	2007	Eur J Heart Failure2007，9，：	1
5	Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations显示文摘	Groenning BA Nilsson JC sondergaard L	2001	Eur J Heart Failure2001，3，6：	1
6	Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure显示文摘	Palazzuoli A Bruni F Puccetfi L	2002	Eur J Heart Failure2002，4，5：	1
7	Self-assessed symptoms in chronic heart failure important information for clinical management显示文摘	Ekman I Kjork E Andersson B	2007	Eur J Heart Failure2007，9，：	1
8	Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure显示文摘	Krack A Richartz BM Gastmaun A	2004	Eur J Heart Fail European journal of heart failure2004，6，4：	1
9	ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology显示文摘	Dickstein K Cohen-Solal A Filippatos G	2008	Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail2008，10，10：	1
10	Self-assessed symptoms in chronic heart failure-Important information for clinical management显示文摘	Ekman I Kj? rk E Andersson B	2007	Eur J Heart Failure2007，，9：	1
11	Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice显示文摘	McGEOCH G LAINCHBURY J TOWN G I	2002	Eur J Heart Failure2002，4，4：	1
12	reversible pulmonary hypertension in heart transplant candidates pretransplant evaluation and outcome after orthotopic heart transplantation显示文摘	Klotz S Deng MC Hanafy D	2003	Eur J heart failure2003，，5：	1
13	Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation 显示文摘	Golbasi Z Ucar O Keles T	2002	Eur J Heart Failure2002，4，5：	1
14	The role of anemia in patients with congestive heart failure:a short review显示文摘	Silverberg DS Wexler D laina A	2008	Eur J Heart Failure2008，10，9：	1
15	Plasma concentrationsof the novel peptide apelin are decreased in patients with chronicheart failure显示文摘	Chong K S Gardner R S Morton J J	2006	Eur J Heart Failure2006，8，：	1
16	Application of NT-pro BNP and BNP measurements in cardiac care:a more discerning maker for the detection and evaluation of heart failure显示文摘	SEINO Y OGAMA A YAMASHITA T	2004	Eur J Heart Failure2004，6，3：	1
17	Influence of age on natriuretic peptides in patients with chronic heart failure a comparison between ANP/NT-ANP and BNP/NT-pro BNP显示文摘	HOGENHUIS J VOORS A A JAARSMA T	2005	Eur J Heart failure2005，7，1：	1
18	Application of NT-proBNP and BNP measurements in cardiac care:a more discerning marker for the detection and evaluation of heart failure显示文摘	SeinoY Ogawa A Yamashita T	2004	Eur J Heart Failure2004，6，3：	1
19	Application of NT-proBNP and BNP ts in cardiac care:a more discerning marker for the detection and evaluation of heart failure 显示文摘	Seino Y Ogawa A Yamashita T	2004	Eur J heart Failure2004，6，3：	1
20	Clinical features and contemporary manangement of patients with cow and preseried ejection fraction heart failure: baseline characteristics of patients in the candesartan in Heart failure -Assessment of Reduction in Mortality and Morbidity(CHARM) Programe显示文摘	McMurray J Ostergren J	2003	Eur J Heart Failure2003，5，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示